Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aflurax vs Nexium in GERD
NCT00184522Phase 4Completed
- Sponsor
- Norwegian University of Science and Technology
- Start
- Aug 2002
- Primary completion
- Nov 2004
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Aflurax in gastroesophageal reflux disease (GERD), sponsored by Norwegian University of Science and Technology. Started Aug 2002; status: completed.
02
Drugs
Aflurax
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00184522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00184522.